Skip to content

A double-blind, randomized, placebo-controlled 12-week human application study to evaluate the efficacy and safety of AG_CTP20A for the improvement of wrinkles, skin moisturization and skin elasticity.

A double-blind, randomized, placebo-controlled 12-week human application study to evaluate the efficacy and safety of M-210712320-01, 02 for the improvement of wrinkles around the eyes, skin moisturization, and skin elasticity.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008499
Enrollment
130
Registered
2023-06-08
Start date
2021-12-27
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : M-210712320-01 : 12 weeks, 1 times a day, 1 bottle (50ml), taken orally (AG_CTP20A 1 g) M-210712320-02 : 12 weeks, 1 times a day, 1 bottle (50ml), taken orally (Control sample

Sponsors

Ellead
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? Women between the ages of 30 and 65 ? Those with wrinkles around the eyes and a photodamage score of 2 to 6 ? A person with a corneometer measurement value of less than 60 on the face ? A person who understands the purpose and content of the test and has expressed willingness to participate voluntarily ? A person who understands possible adverse reactions and signs a written consent form ? Healthy subjects without acute or chronic physical diseases including skin diseases (eczematous skin diseases such as atopic dermatitis, severe infectious skin diseases) that may affect the test ? A person who can be followed up during the test period ? A person who can schedule visits during the test period and follow research instructions ? A person who can restrict the use of similar health functional foods, cosmetics, or medicines during the test period

Exclusion criteria

Exclusion criteria: ? Serious acute kidney disease, heart disease, liver disease, or other chronic disease [diabetes, hypertension (systolic 140 mmHg or more or diastolic 90 mmHg or more), hypotension (systolic 90 mmHg or less), etc.] that could affect the test results within the last 6 months; Those suffering from chronic wasting diseases (hyperthyroidism and hypothyroidism, asthma, etc.) ? A person who has abnormalities in the overall findings of a specialist as a result of blood and urine tests ? Persons with serious psychiatric disorders ? Those with psoriasis (taking immunosuppressants) or severe atopic dermatitis (sore symptoms, systemic symptoms, taking steroids) ? A person with a specific allergic constitution (medicine, cosmetics, food, pollen, ultraviolet rays, etc.) or sensitive or hypersensitive skin ? Those who are pregnant, lactating, or planning to become pregnant ? A person who lacks the energy and nutrients necessary for mental or physical activities, including life support ? A drug or alcohol addict ? Subjects with skin abnormalities such as moles, acne, tattoos, scars, erythema, capillary dilation, and burn marks at the test site ? Those who have not passed 6 months since participating in the same test ? Those who have used oral and topical retinoids/steroids, etc., or who have undergone dermatological treatments that may affect the test, such as skin peeling or laser treatment, within 6 months before the start of the test ? Those who are taking anti-obesity drugs (absorption inhibitors, antidepressants, appetite suppressants, etc.), contraceptives, or female hormones ? Those who have undergone surgery on the test site within 6 months before the start of the test ? A person who is participating in the same part or the same human body application test of this / other institution ? Those who are considered unsuitable for the test by the research director's judgment

Design outcomes

Primary

MeasureTime frame
Measurement of crow’s feet;Measurement of skin moisturizing;Measurement of skin elasticity

Secondary

MeasureTime frame
safety assessment

Countries

Korea, Republic of

Contacts

Public ContactYeo Cho Yoon

Amicogen

ycyoon@amicogen.com+82-70-4266-7459

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026